Continuation Protocol for Obstructive Sleep Apnea (OSA)
A Phase 3 Open Label Continuation Protocol of a Fixed Dose Combination of Aroxybutynin and Atomoxetine (AD109) in Obstructive Sleep Apnea
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Phase 3
Contacts and Locations
Study Contact
Study Contact
- Name: Ron Farkas, MD
- Phone Number: 6175008880
- Email: info@apnimed.com
Study Contact Backup
- Name: Luigi Taranto, MD, MD
- Email: info@apnimed.com
Study Locations
-
-
British Columbia
-
Kelowna, British Columbia, Canada, VIY 4N7
- Medical Arts Health Research Group
-
-
Ontario
-
Markham, Ontario, Canada, L3R 1A3
- AMNDX Inc
-
Ottawa, Ontario, Canada, K2C 0P7
- West Ottawa Sleep Centre
-
Toronto, Ontario, Canada, M3J 0K2
- Canadian Phase Onward Inc.
-
Toronto, Ontario, Canada, M5S 3A3
- Jodha Tishon, Inc.
-
-
Quebec
-
Montreal, Quebec, Canada, H4A 3J1
- McGill University Health Centre
-
-
-
-
Alabama
-
Birmingham, Alabama, United States, 35213
- Sleep Disorders Center of America
-
Tuscaloosa, Alabama, United States, 35401
- The University of Alabama/Institute for Rural Health Research
-
-
Arizona
-
Chandler, Arizona, United States, 85224
- Chandler Clinical Trials
-
Mesa, Arizona, United States, 85213
- Desert Clinical Reserach, LLC/CCT Research
-
Phoenix, Arizona, United States, 85044
- Foothills Research Center/CCT Research
-
Tempe, Arizona, United States, 85283
- Fiel Family and Sports Medicine/CCT Research
-
Tucson, Arizona, United States, 85704
- Noble Clinical Research
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72211
- Preferred Research Partners, Inc.
-
-
California
-
Anaheim, California, United States, 92801
- Orange County Research Institute
-
Cerritos, California, United States, 90703
- Core Healthcare Group
-
Chula Vista, California, United States, 91910
- Exalt Clinical Research, Inc.
-
Los Alamitos, California, United States, 90720
- Collaborative Neuroscience Research, LLC
-
Los Angeles, California, United States, 90025
- Santa Monica Clinical Trials
-
Pomona, California, United States, 91767
- Empire Clinical Research
-
Riverside, California, United States, 92501
- Probe Clinical Research Corporation
-
San Diego, California, United States, 92103
- Pacific Research Network
-
San Ramon, California, United States, 94583
- TriValley Sleep Center
-
Santa Ana, California, United States, 92705
- SDS Clinical Trials, Inc.
-
West Covina, California, United States, 91790
- Provideré Research Inc.
-
-
Colorado
-
Denver, Colorado, United States, 80209
- Mountain View Clinical Research, Inc.
-
-
Florida
-
Brandon, Florida, United States, 33511
- Meris Clinical Research
-
Brandon, Florida, United States, 33511
- Teradan Clinical Trials
-
Clearwater, Florida, United States, 33765
- St. Francis Medical Institute
-
Cutler Bay, Florida, United States, 33189
- Nouvelle Clinical Research
-
Daytona Beach, Florida, United States, 32117
- Arrow Clinical Trials
-
Lake Worth, Florida, United States, 33467
- Canvas Clinical Research
-
Lehigh Acres, Florida, United States, 33971
- Florida Lung & Sleep Associates
-
Miami, Florida, United States, 33174
- Advanced Medical Research Institute
-
Miami, Florida, United States, 33155
- Ivetmar Medical Group, LLC
-
Miami, Florida, United States, 33176
- PharmaDev Clinical Research Institute, LLC
-
Miami, Florida, United States, 33186
- Flourish Research
-
Ocala, Florida, United States, 34470
- Renstar Medical Research
-
Orlando, Florida, United States, 32801
- Clinical Neuroscience Solutions, Inc.
-
Tampa, Florida, United States, 33634
- JSV Clinical Research Study Inc.
-
West Palm Beach, Florida, United States, 33409
- Palm Beach Research Center
-
Winter Park, Florida, United States, 32789
- Clinical Site Partners, LLC dba Flourish Research
-
Winter Park, Florida, United States, 32789
- Central Florida Pediatric Sleep Disorders d/b/a Florida Pediatric Institute, LLC
-
-
Georgia
-
Atlanta, Georgia, United States, 30331
- Atlanta Center for Medical Research
-
Atlanta, Georgia, United States, 30328
- Neurotrials Research Inc
-
Decatur, Georgia, United States, 30030
- CenExel iResearch, LLC
-
Suwanee, Georgia, United States, 30024
- Georgia Neurology and Sleep Medicine Associates
-
Valdosta, Georgia, United States, 31605
- Medster Research
-
-
Idaho
-
Meridian, Idaho, United States, 83642
- St. Luke's Idaho Pulmonary Associates - Meridian Clinic
-
-
Illinois
-
Chicago, Illinois, United States, 60634
- Chicago Research Center, Inc.
-
-
Kansas
-
Kansas City, Kansas, United States, 66160
- University of Kansas Medical Center
-
-
Kentucky
-
Louisville, Kentucky, United States, 40220
- Advanced ENT and Allergy
-
-
Maryland
-
Columbia, Maryland, United States, 21045
- Centennial Medical Group Research Department
-
Glen Burnie, Maryland, United States, 21061
- Sleep Disorders Centers of the Mid-Atlantic
-
Rockville, Maryland, United States, 20854
- Velocity Clinical Research
-
-
Massachusetts
-
Newton, Massachusetts, United States, 02459
- Neurocare, Inc.
-
North Dartmouth, Massachusetts, United States, 02747
- Infinity Medical Research
-
Springfield, Massachusetts, United States, 01107
- Baystate Clinical Trials Unit
-
-
Michigan
-
Ann Arbor, Michigan, United States, 48109
- University of Michigan Clinical Research Unit
-
Lathrup Village, Michigan, United States, 48076
- Revive Research Institute, Inc.
-
Novi, Michigan, United States, 48377
- Henry Ford Medical Center - Columbus
-
Sterling Heights, Michigan, United States, 48314
- Clinical Neurophysiology Services PC
-
-
Missouri
-
Chesterfield, Missouri, United States, 63017
- Sleep Medicine and Research Center, St. Luke's Hospital
-
Hazelwood, Missouri, United States, 63042
- Healthcare Research Network
-
St. Louis, Missouri, United States, 63123
- Clayton Sleep Institute, Llc
-
-
Nevada
-
Henderson, Nevada, United States, 89052
- Henderson Clinical Trials
-
North Las Vegas, Nevada, United States, 89030
- Las Vegas Clinical Trials, LLC
-
-
New Jersey
-
Eatontown, New Jersey, United States, 07724
- Clinilabs Drug Development Corporation
-
Neptune, New Jersey, United States, 07753
- Sleep Dynamics
-
-
New Mexico
-
Albuquerque, New Mexico, United States, 87107
- Maimonides Sleep Arts & Sciences
-
-
New York
-
New Hyde Park, New York, United States, 11042
- Northwell Health
-
-
North Carolina
-
Denver, North Carolina, United States, 28037
- Research Carolina Elite
-
Gastonia, North Carolina, United States, 28054
- Clinical Research of Gastonia
-
High Point, North Carolina, United States, 27260
- Peters Medical Research LLC
-
Huntersville, North Carolina, United States, 28078
- Advanced Respiratory and Sleep Medicine
-
New Bern, North Carolina, United States, 28562
- Coastal Carolina Health Care, P.A. Pulmonary and Sleep Medicine
-
Wilmington, North Carolina, United States, 28412
- Accellacare
-
-
North Dakota
-
Fargo, North Dakota, United States, 58104
- Lillestol Research
-
-
Ohio
-
Canton, Ohio, United States, 44718
- Neuroscience Research Center, LLC
-
Cincinnati, Ohio, United States, 45212
- CTI Clinical Research Center
-
Cincinnati, Ohio, United States, 45245
- Intrepid Research, LLC
-
-
Oregon
-
Portland, Oregon, United States, 97202
- Northwest Research Center
-
-
Pennsylvania
-
Abington, Pennsylvania, United States, 19001
- Abington Neurological Associates
-
Wyomissing, Pennsylvania, United States, 19610
- Respiratory Specialists
-
-
South Carolina
-
Charleston, South Carolina, United States, 29406
- Lowcountry Lung and Critical Care, PA
-
Greenville, South Carolina, United States, 29607
- Tribe Clinical Research, LLC
-
Greenville, South Carolina, United States, 29615
- Velocity Clinical Research, Greenville
-
Rock Hill, South Carolina, United States, 29732
- OnSite Clinical Solutions, LLC
-
-
Tennessee
-
Chattanooga, Tennessee, United States, 37404
- Chattanooga Research & Medicine
-
Memphis, Tennessee, United States, 38119
- Clinical Neuroscience Solutions, Inc.
-
-
Texas
-
Austin, Texas, United States, 78731
- FutureSearch Trials of Neurology
-
Dallas, Texas, United States, 75231
- FutureSearch Trials of Dallas
-
Houston, Texas, United States, 77043
- Memorial Hermann Village
-
Houston, Texas, United States, 77070
- Houston Clinical Research Associates
-
Huntsville, Texas, United States, 77340
- Huntsville Research Institute
-
San Antonio, Texas, United States, 78258
- Element Research Group
-
San Antonio, Texas, United States, 78229
- Sleep Therapy and Research Center
-
-
Utah
-
South Ogden, Utah, United States, 84405
- South Ogden Family Medicine/CCT Research
-
-
Virginia
-
Vienna, Virginia, United States, 22182
- Sleep Disorder Center of the Mid-Atlantic
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Completion of APC-APN-304 without permanent discontinuation of IMP.
- Completion of APC-APN-305 without permanent discontinuation of IMP.
Exclusion Criteria:
- Participants are excluded from the study if participation would be considered unsafe by the investigator based on the individual's current status.
- Participants are excluded from the study if participation would be considered unsafe by the investigator based on concomitant therapies.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: AD109
Open Label AD109
|
Fixed Dose Combination
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants With Adverse Events (AES) and Serious Adverse Events (SAEs)
Time Frame: through study completion, an average of 1 year
|
An AE is any untoward medical occurrence in a participant or clinical study participant, temporally associated with the use of a study treatment, whether or not considered related to the medicinal product.
An AE can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease (new or exacerbated) temporally associated with the use of a study treatment.
An SAE was an AE during any study phase that fulfills one or more of the following criteria: results in death, life threatening (The term 'life-threatening' in the definition of 'serious' refers to an event in which the participant was at risk of death at the time of the event.
It does not refer to an event, which hypothetically might have caused death, if it were more severe), requires inpatient hospitalization or prolongation of existing hospitalization, results in persistent disability/incapacity.
|
through study completion, an average of 1 year
|
|
Number of Participants With Vital Signs Abnormalities
Time Frame: through study completion, an average of 1 year
|
Vital signs that are planned to be assessed include parameters such as weight,heart rate and systolic and diastolic blood pressure.
|
through study completion, an average of 1 year
|
|
Number of Participants With Concomitant Therapy (Medication or Devices)
Time Frame: through study completion, an average of 1 year
|
Concomitant therapy with devices (i.e., CPAP) and concomitant medications are other prescription medications, over-the-counter (OTC) drugs or dietary supplements that a study participant takes in addition to the drug under investigation.
|
through study completion, an average of 1 year
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Director: Ron Farkas, MD, Apnimed
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Respiration Disorders
- Sleep Wake Disorders
- Apnea
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Apnea Syndromes
- Sleep Apnea, Obstructive
- Physiological Effects of Drugs
- Molecular Mechanisms of Pharmacological Action
- Neurotransmitter Agents
- Membrane Transport Modulators
- Adrenergic Agents
- Neurotransmitter Uptake Inhibitors
- Adrenergic Uptake Inhibitors
- Atomoxetine Hydrochloride
Other Study ID Numbers
Other Study ID Numbers
- APC-APN-306
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.